SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SangStat Med. (SANG) - 10 of 10 analysts say Strong Buy
SANG 5.040+1.6%Dec 30 3:55 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Doug who wrote (115)6/9/1998 3:28:00 PM
From: Richard Haugland  Read Replies (1) of 184
 
Doug, sorry I am zero for five on your questions. Although I am a chemist and business owner, I don't know the economics of the pharmaceutical or medical fields. I would expect manufacturing margins to eventually be very high like most drugs but there are a lot of costs to amortize. From what I understand about liability, the patients are always required to sign informed consent forms to take care of much of this and the treatments that SANG is developing are far from guaranteed to be successful in all cases.

From what I read on the SANG Novartis board, it is far more likely that SANG will be sued by Novartis:

messages.yahoo.com@m2.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext